Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04608032
Other study ID # 10477M-NARCIS
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 8, 2020
Est. completion date December 1, 2024

Study information

Verified date February 2024
Source Centre hospitalier de Ville-Evrard, France
Contact Dominique JANUEL, MBBS
Phone 0143093232
Email d.januel@epsve.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effect of a cognitive remediation program on neurocognitive, social cognitive and metacognitive functions designed for patients living with a schizophrenia spectrum disorder.


Description:

Evaluation of the specific therapeutic efficacy of the ecological cognitive remediation program for schizophrenia spectrum disorder [ECo-Sz] on neurocognitive deficits, social cognition deficits and metacognition deficits of patients with a schizophrenia spectrum disorder. In this double-blind (patients, outcomes assessors) controlled randomized trial the investigators compare patients receiving Ecological Cognitive training program for schizophrenia spectrum disorder [ECo-Sz] to patients benefiting from recovery-oriented therapy [ThOR]. Patients are treated for two months and monitored for four months.


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date December 1, 2024
Est. primary completion date December 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Schizophrenia Disorder diagnosis, according to Diagnostic and Statistical Manual of mental disorders - Fifth edition (DSM-V) - Patient stabilized in terms of positive and negative symptomatology (absence or presence of weak positive and negative symptoms) - Positive and Negative stable symptoms (no or few positive and negative symptoms) - Stable and effective minimum dose of medication (antipsychotic) for the last three months - Cognitive complaint expressed by the patient - Informed consent form read, initialed and signed - Understanding of spoken and read French - Patient registered on the social welfare system Exclusion Criteria: - Other diagnosis at the forefront than Schizophrenia of the DSM-V - Medical history neurological disorder resulting in hospitalization - Acute episode in the last three month - Somatic disorders resulting in cognitive impairment - Engagement in a research protocol either currently or over the last month - Neuropsychological assessment evaluation during the last six month - Patients under the protection of a conservator (simple or reinforced) - Individuals in vulnerable circumstances

Study Design


Intervention

Other:
[Eco-Sz] Ecological Cognitive training program for schizophrenia spectrum disorder
The first group will have [Eco-Sz] Ecological Cognitive training program for schizophrenia spectrum disorder
Recovery-Oriented Therapy
The second group will have [THoR] Recovery-Oriented Therapy

Locations

Country Name City State
France Ch Ville Evrard Neuilly-sur-Marne
France URC Ville Evrard Neuilly-sur-Marne

Sponsors (1)

Lead Sponsor Collaborator
Centre hospitalier de Ville-Evrard, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Other FAUX-PAS Test A test assessing first and second degree theory of mind through short stories and pictures involved two or three characters - minimum value = 0 - maximum value = 60 First week
Other FAUX-PAS Test A test assessing first and second degree theory of mind through short stories and pictures involved two or three characters - minimum value = 0 - maximum value = 60 Ten week week
Other FAUX-PAS Test A test assessing first and second degree theory of mind through short stories and pictures involved two or three characters - minimum value = 0 - maximum value = 60 Eighteen week week
Other FAUX-PAS Test A test assessing first and second degree theory of mind through short stories and pictures involved two or three characters - minimum value = 0 - maximum value = 60 Twenty six week
Other The Rey/Taylor complex figure test The test is a neuropsychological assessment in which examinees are asked to reproduce a complicated line drawing, first by ping it freehand and then drawing from memory. This test permits the evaluation of visuospatial abilities, memory, attention, planning and working memory - minimum value = 0 - maximum value = 36 First week
Other The Rey/Taylor complex figure test The test is a neuropsychological assessment in which examinees are asked to reproduce a complicated line drawing, first by ping it freehand and then drawing from memory. This test permits the evaluation of visuospatial abilities, memory, attention, planning and working memory - minimum value = 0 - maximum value = 36 Ten week
Other The Rey/Taylor complex figure test The test is a neuropsychological assessment in which examinees are asked to reproduce a complicated line drawing, first by ping it freehand and then drawing from memory. This test permits the evaluation of visuospatial abilities, memory, attention, planning and working memory - minimum value = 0 - maximum value = 36 Eighteen week
Other The Rey/Taylor complex figure test The test is a neuropsychological assessment in which examinees are asked to reproduce a complicated line drawing, first by ping it freehand and then drawing from memory. This test permits the evaluation of visuospatial abilities, memory, attention, planning and working memory - minimum value = 0 - maximum value = 36 Twenty six week
Other MEM IV Logical Memory Composite score of the Weschler Memory Scale - fourth edition First week
Other MEM IV Logical Memory Composite score of the Weschler Memory Scale - fourth edition - minimum value = 0 - maximum value = 20 Ten week
Other MEM IV Logical Memory Composite score of the Weschler Memory Scale - fourth edition - minimum value = 0 - maximum value = 20 Eighteen week
Other MEM IV Logical Memory Composite score of the Weschler Memory Scale - fourth edition - minimum value = 0 - maximum value = 20 Twenty six week
Other MEM IV Symbol Memory Composite score of the Weschler Memory Scale - fourth edition - minimum value = 0 - maximum value = 20 First week
Other MEM IV Symbol Memory Composite score of the Weschler Memory Scale - fourth edition - minimum value = 0 - maximum value = 20 Ten week
Other MEM IV Symbol Memory Composite score of the Weschler Memory Scale - fourth edition - minimum value = 0 - maximum value = 20 Eighteen week
Other MEM IV Symbol Memory Composite score of the Weschler Memory Scale - fourth edition - minimum value = 0 - maximum value = 20 Twenty six week
Other The Balloon Analogue Risk Task The Balloon Analogue Risk Task is a computerized measure of risk taking behavior - no minimum or maximum value First week
Other The Balloon Analogue Risk Task The Balloon Analogue Risk Task is a computerized measure of risk taking behavior - no minimum or maximum value Ten week
Other The Balloon Analogue Risk Task The Balloon Analogue Risk Task is a computerized measure of risk taking behavior - no minimum or maximum value Eighteen week
Other The Balloon Analogue Risk Task The Balloon Analogue Risk Task is a computerized measure of risk taking behavior - no minimum or maximum value Twenty six week
Other D2 Test The test is neuropsychological measure of selective and sustained attention and visual scanning speed - no minimum or maximum value First week
Other D2 Test The test is neuropsychological measure of selective and sustained attention and visual scanning speed - no minimum or maximum value Ten week
Other D2 Test The test is neuropsychological measure of selective and sustained attention and visual scanning speed - no minimum or maximum value Eighteen week
Other D2 Test The test is neuropsychological measure of selective and sustained attention and visual scanning speed - no minimum or maximum value Twenty six week
Other ToM-15 The test is a task assessing theory of mind abilities you cannot move more than one disk at a time; a disk can only be placed on another disk larger than it or on an empty location - no minimum or maximum value First week
Other ToM-15 The test is a task assessing theory of mind abilities you cannot move more than one disk at a time; a disk can only be placed on another disk larger than it or on an empty location - no minimum or maximum value Ten week
Other ToM-15 The test is a task assessing theory of mind abilities you cannot move more than one disk at a time; a disk can only be placed on another disk larger than it or on an empty location - no minimum or maximum value Eighteen week
Other ToM-15 The test is a task assessing theory of mind abilities you cannot move more than one disk at a time; a disk can only be placed on another disk larger than it or on an empty location - no minimum or maximum value Twenty six week
Other Cubes Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 First week
Other Cubes Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 Ten week
Other Cubes Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 Eighteen week
Other Cubes Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 Twenty six week
Other Visual Puzzle Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 First week
Other Visual Puzzle Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 Ten week
Other Visual Puzzle Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 Eighteen week
Other Visual Puzzle Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 Twenty six week
Other Similiraties Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 First week
Other Similiraties Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 Ten week
Other Similiraties Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 Eighteen week
Other Similiraties Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 Twenty six week
Other Working Memory Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 First week
Other Working Memory Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 Ten week
Other Working Memory Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 Eighteen week
Other Working Memory Subtest Composite score of Weschler Adult Intelligence Scale - fourth edition - minimum value = 0 - maximum value = 20 Twenty six week
Primary STROOP Interference score pre-inclusion
Primary TMTB Trail Making Test pre-inclusion
Primary Litteral score of Verbal fluences Litteral score of Verbal fluences pre-inclusion
Primary GO/NOGO cognitive control score pre-inclusion
Primary tower of Hanoi Tower planning total score from tower of Hanoi pre-inclusion
Primary Matrix test (WAIS-IV) The perceptual reasoning score of the Matrix test. pre-inclusion
Secondary Mini-500 (Entretien structuré Neuropsychiatrique International pre-inclusion
Secondary CTQ Childhood Trauma Questionnaire - minimum value = 28 - maximum value = 112 pre-inclusion
Secondary PANSS Positive and Negative Syndrome Scale - minimum value = 30 - maximum value = 210 pre-inclusion
Secondary EESEP Self-Efficacity Rating Scale - minimum value = 21 - maximum value = 105 Eighteen week
Secondary EESEP Self-Efficacity Rating Scale - minimum value = 21 - maximum value = 105 Twenty six week
Secondary ERF Functional Impact Scale - minimum value = 5 - maximum value = 35 First week
Secondary ERF Functional Impact Scale - minimum value = 5 - maximum value = 35 Ten week
Secondary ERF Functional Impact Scale - minimum value = 5 - maximum value = 35 Eighteen week
Secondary ERF Functional Impact Scale - minimum value = 5 - maximum value = 35 Twenty six week
Secondary ERF-CS Functional Impact Scale for Social Cognition disorders- minimum value = 4 - maximum value = 20 First week
Secondary ERF-CS Functional Impact Scale for Social Cognition disorders- minimum value = 4 - maximum value = 20 Ten week
Secondary ERF-CS Functional Impact Scale for Social Cognition disorders- minimum value = 4 - maximum value = 20 Eighteen week
Secondary ERF-CS Functional Impact Scale for Social Cognition disorders- minimum value = 4 - maximum value = 20 Twenty six week
Secondary MCQ-30 Short French Meta-Cognitions Questionnaire - minimum value = 30 - maximum value = 120 First week
Secondary MCQ-30 Short French Meta-Cognitions Questionnaire - minimum value = 30 - maximum value = 120 Ten week
Secondary MCQ-30 Short French Meta-Cognitions Questionnaire - minimum value = 30 - maximum value = 120 Eighteen week
Secondary MCQ-30 Short French Meta-Cognitions Questionnaire - minimum value = 30 - maximum value = 120 Twenty six week
Secondary QFS Social Functioning Questionnaire - no minimum or maximum value First week
Secondary QFS Social Functioning Questionnaire - no minimum or maximum value Ten week
Secondary QFS Social Functioning Questionnaire - no minimum or maximum value Eighteen week
Secondary QFS Social Functioning Questionnaire - no minimum or maximum value Twenty six week
Secondary SAIQ Self-Appraisal of Illness Questionnaire - minimum value = 17- maximum value = 68 First week
Secondary SAIQ Self-Appraisal of Illness Questionnaire - minimum value = 17- maximum value = 68 Ten week
Secondary SAIQ Self-Appraisal of Illness Questionnaire - minimum value = 17- maximum value = 68 Eighteen week
Secondary SAIQ Self-Appraisal of Illness Questionnaire - minimum value = 17- maximum value = 68 Twenty six week
Secondary SCS Revised Self-Consciousness Scale - minimum value = 0 - maximum value = 66 First week
Secondary SCS Revised Self-Consciousness Scale- minimum value = 0 - maximum value = 66 Ten week
Secondary SCS Revised Self-Consciousness Scale - minimum value = 0 - maximum value = 66 Eighteen week
Secondary SCS Revised Self-Consciousness Scale - minimum value = 0 - maximum value = 66 Twenty six week
Secondary SDS Social Desirability Scale - minimum value = 0 - maximum value = 33 First week
Secondary SDS Social Desirability Scale - minimum value = 0 - maximum value = 33 Ten week
Secondary SDS Social Desirability Scale - minimum value = 0 - maximum value = 33 Eighteen week
Secondary SDS Social Desirability Scale - minimum value = 0 - maximum value = 33 Twenty six week
Secondary STORI Stage of Recovery Instrument - minimum value = 0 - maximum value = 50 First week
Secondary STORI Stage of Recovery Instrument - minimum value = 0 - maximum value = 50 Ten week
Secondary STORI Stage of Recovery Instrument - minimum value = 0 - maximum value = 50 Eighteen week
Secondary STORI Stage of Recovery Instrument - minimum value = 0 - maximum value = 50 Twenty six week
See also
  Status Clinical Trial Phase
Terminated NCT00660595 - Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose Phase 3
Completed NCT02655172 - Have a Good Grasp of the Worldthe World N/A
Completed NCT01729650 - Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor) N/A
Completed NCT01606436 - A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia Phase 1
Completed NCT02525315 - Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Auditory Hallucinations Phase 2
Completed NCT00488319 - Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia. Phase 3
Completed NCT00088491 - Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia Phase 3
Completed NCT01279213 - Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia Phase 4
Completed NCT00600756 - Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone Phase 3
Completed NCT00572247 - The Psychiatric Rehabilitation Approach to Weight Loss N/A
Completed NCT00491569 - Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia Phase 2
Completed NCT00328276 - Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia Phase 2
Completed NCT00485823 - Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia Phase 4
Active, not recruiting NCT00161408 - Psychological Intervention for Relapse Prevention in First Episode Schizophrenia N/A
Terminated NCT05164289 - Interest of EMDR Schizophrenic Disorders
Withdrawn NCT00276263 - Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia Phase 2
Completed NCT00088465 - Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder Phase 3
Withdrawn NCT02654405 - Sodium Butyrate For Improving Cognitive Function In Schizophrenia Phase 2/Phase 3
Completed NCT02544516 - Upside Down, Give me the Handle N/A
Completed NCT00960219 - D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia Phase 2